New indication for Byetta

Byetta (exenatide) is now licensed for use alongside insulin.

The dose of insulin may need to be reduced when Byetta is used as an adjunct, especially in patients at risk of hypoglycaemia
The dose of insulin may need to be reduced when Byetta is used as an adjunct, especially in patients at risk of hypoglycaemia

Byetta (exenatide) is indicated as an adjunct to basal insulin with or without metformin and/or pioglitazone in adults with type 2 diabetes who have not achieved adequate glycaemic control with these agents.

In a 30-week study, patients received twice-daily exenatide or placebo, in addition to insulin glargine (with or without metformin, pioglitazone or both). The dose of insulin glargine was titrated to achieve a target fasting plasma glucose of approximately 5.6mmol/l.

At the end of the study, patients receiving exenatide (n=137) showed greater reductions in HbA1c and body weight than those on placebo (n=122). HbA1c declined by 1.7% in the exenatide group and 1.0% in the placebo group. From baseline, body weight decreased in the exenatide group by 1.8kg but increased by 1.0kg in the control group.

A greater proportion of patients achieved HbA1c targets of <7% and ≤6.5% in the exenatide group than in the placebo group: 56% versus 29% and 42% versus 13%, respectively.

View Byetta drug record

Further information: Lilly Eli & Co Ltd

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Asthma and COPD Preparations and Compatible Devices

Asthma and COPD Preparations and Compatible Devices

Available presentations of bronchodilators and anti-inflammatories.

Ranitidine in short supply after contamination fears prompt precautionary recall

Ranitidine in short supply after contamination fears prompt precautionary recall

GPs have reported shortages of ranitidine following...

Drug shortages - live tracker

Drug shortages - live tracker

Added: Alzhok and ranitidine oral soln.
Use our...

Excessive steroid dosing highlighted in inflammatory bowel disease

Excessive steroid dosing highlighted in inflammatory bowel disease

Some patients with Crohn's disease or ulcerative colitis...